Today: November 18, 2018 10:27 am
Location Kit

Tag: Medical pharmaceutical products


A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
November 7, 2018

VolitionRx Restricted publicizes the monetary outcomes and the industrial replace for the third quarter of 2018

Cameron ReynoldsThe President and CEO of Volition mentioned: "We’ve got made nice progress on this space, typically, with more often than not of completion of a personal placement (PIPE). $ 9 million (excluding any product from the train of the order); guaranteeing an extra $ 700,000 in non-dilutive funds of the Walloon regional authorities; and extra not too long ago, the train of excellent ensures that supplied roughly $ 717,000 In further funds to the corporate. " Mr. Reynolds commented: "The primary investigation can be launched sooner or later and is anticipated...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 29, 2018

Oxurion NV broadcasts the appointment of Adrienne Graves on its Board of Administrators

Louvain, Belgium, October 29, 2018 / PRNewswire / – Oxurion NV (Euronext Brussels: OXUR – previously generally known as ThromboGenics Nevada), a biopharmaceutical firm that develops modern remedies to protect imaginative and prescient within the eyes of sufferers with eye ailments, at the moment introduced the appointment of Adrienne Graves, Ph.D., to its board of administrators. Dr. Graves will substitute Paul howes, who has been a board member since 2014. "I'm honored to be named for the blackboard of administrators in Oxurion, " mentioned Dr. Critical "The corporate has constructed a various...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 29, 2018

CannTrust expands world attain and entry to the Asia Pacific area as an investor of Cannatrek Cornerstone

VAUGHAN, IN, October 28, 2018 / PRNewswire / – CannTrust Holdings Inc. ("CannTrust" or the "Firm") (TSX: TRST), considered one of Glen Cannatrek Ltd ("Cannatrek"), Cannatrek Ltd, is likely one of the largest and most profitable hashish producers on the earth. Cannatrek is likely one of the first vertically built-in Australian corporations that obtains a license for analysis, cultivation, manufacture, sale and importation of hashish of 1.7 million m2. foot greenhouse set up, which can place Australia. This greenhouse venture, when accomplished, will present a big provide to the Asia-Pacific area and...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 29, 2018

Proof signifies that a watch scanner can detect early Alzheimer's illness

CHICAGO, October 28, 2018 / PRNewswire / – The outcomes of two research present {that a} new non-invasive imaging system can see the indicators of Alzheimer's illness in a matter of seconds. The researchers present that the small blood vessels within the retina are altered in sufferers with Alzheimer's. Even sufferers who’ve a household historical past of Alzheimer's with out signs present these telltale indicators. And so they confirmed that they can distinguish between Alzheimer's illness and people with gentle cognitive impairment. The outcomes of those research are introduced in AAO 2018,...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

MGI stellt MGISEQ-T7 vor, das bahnbrechende Sequencing-System with ultrahhem Durchsatz

"Ab sofort haben Kunden die volle Flexibilät zur Durchführung einer breiten Palette von gleichzeitigen Sequenzierungsvorgängen – alle in einem einzigen Gerätt", MGI-CEO Feng Mu. The Die Innovationen von MGISEQ-T7 umfassen: Einzigartige Quad-Flowcell-Plattform, die den unabhängigen Betrieb von 1-Four Chips unterstützt Eine revolutionäre Quad-Flowcell-Plattform zur unabhängigen Verarbeitung von Flusszellen mit unterschiedlichen Leselängen und Anwendungen, die jederzeit und einem einz einzigen Durchlauf erfolgen kann. Common data kind, Exom-Sequenzierung mit maximaler Sequenzierungstiefe, Epigenom-Sequenzierung und großformatige Tumorgen-Bestimmung. Sequenzierungsgeschwindigkeit um mehr als 50% verbessertMGISEQ-T7 comprises directions on find out how to open the system and the set...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

MGI presents its revolutionary extremely excessive efficiency sequencer, MGISEQ-T7

"Now clients have full flexibility for a variety of sequences, on the identical time and a single machine," he says. Feng Mu, CEO of MGI. The improvements of the MGISEQ-T7 embody: A single quadruple movement cell platform that helps unbiased operation of between 1 and four chips A revolutionary movement cell platform permits a number of movement cells with totally different studying lengths and functions to be processed independently at any time and in a single go. The platform helps full genome sequencing, ultra-deep deluoma drying, epigenome sequencing and detection of huge...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

MGI prichádza s prelomovým ultravysoko priepustným sekvenovacím zariadením MGISEQ-T7

"Zákazníkom umožníme dosiahnuť úplnú flexibilitu pri realizácii širokého spektra procesv sekvenovania naraz a v jednom zariadení," uviedol generaliany riaditeľ MGI Feng Mu. Invoácie zariadenia MGISEQ-T7: Jedinečná platforma štvorstupňového bunkového toku podporujúca nezávislé operácie 1 až four čipov Revolučná štvorstupňová bunková platforma umožňuje niekoľko bunkových tokov zároveň s rôznymi dĺžkami čítania a aplikácie, ktoré je možné spracovávať nezávisle, kedykoľvekk. Platform and utility of the key phrase utility, sekvenovaní ultra-hlbokého exómu, sekvenovaní epigenómu pri detekcii nádorových genov. Zvýšenie rýchlosti sekvenovania or viac ako 50%MGISEQ-T7 I najrýchlejšie sekvenovacie zariadenie na trhu. Minutes PE150 dokáže realizovať...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

MGI представляет революционный сверхпроизводительный секвенатор MGISEQ-T7

"Пользователи новой модели получают абсолютную гибкость для одновременного выполнения широкого спектра операций секвенирования посредством единого устройства" – прокомментировал директор генеральный MGI Фэн Му (Feng Mu). В число инноваций MGISEQ-T7 входят: Уникальная платформа с четырьмя проточными ячейками, поддержинаювисологольевельское сезавасиковасельевеновереветеревеное коваюРеволюционная платформа позволяет проточным ячейкам функционировать независимо друг от друга с различной длиной считывания и различными задачами в рамках единой операции. Платформа поддерживает операции полногеномного секвенирования, сверхглубокого экзомного секвенирования, эпигеномного секвенирования и крупнопанельной детекции опухолевых генов. Повышение скорости секвенирования более чем на 50%MGISEQ-T7 работает гораздо быстрее любого из существующих аналогов. На выполнение операции PE150...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

The 2-year knowledge for Novartis brolucizumab reaffirm the prevalence to aflibercept in fluid discount in sufferers with DMN

HANOVER DEL ESTE, N.J., October 27, 2018 / PRNewswire / – Novartis declares further outcomes of second section brolucizumab Part III that reaffirmed optimistic first 12 months outcomes. Brolucizumab places its main endpoint of noninferiority to aflibercept in one of the best corrected visible acuity (MCVA) and confirmed a superiority in the important thing retinal ends in one (48 weeks)1.2. The secondary endpoints in two years (96 weeks) reaffirmed the prevalence of brolucizumab 6 mg within the discount of retinal fluid, an vital marker of illness exercise in sufferers with age-related macular...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 27, 2018

MGI przedstawia przełomowy sekwenser MGISEQ-T7 charakteryzujący się extremely dużą przepustowością

– Klienci mają teraz większą elastyczność w szerszym zakresie sekwencjonowania w tym samym czasie w jednym urządzeniu – skomentował główny dyrektor wykonawczy firmy MGI Feng Mu. Poniżej przedstawione s innowacyjne rozwiązania w modelu MGISEQ-T7. Wyjątkowe rozwiązanie poczwórnych kuwet przepływowych, które pozwala na niezależne działanie of 1 do four chipówRewolucyjne rozwiązanie poczwórnych kuwet przepływowych umo wikorzystanie wielu kuwet z różnymi długościami please on this case, so that you have in mind this text. Platforma umożliwia sekwencjonowanie całego genomu, doglębne sekwencjonowanie egzonów, sekwencjonowanie epigenomu oraz szeroko panelowe wykrywanie genów nowotworowych. Prędkość sekwencjonowania szybsza or...

Continue Reading
Share